Publication | Closed Access

Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy

Alzheimer's DiseaseDementiaVascular DementiaFrontotemporal DementiaSustained ImprovementsRehabilitationNeurologyAging-associated DiseaseNeurodegenerationMedicineTreatmentCerebrolysin TherapyLewy Body Dementia